Summary

Laboratory Corporation of America Holdings (LabCorp) is an independent clinical laboratory company engaged in developing and commercializing a wide range of new diagnostic technologies and testing services. The company divides its products into two reportable segments namely the Clinical diagnostics laboratory segment , which includes core testing as well as genomic and esoteric testing, and Others, which includes the Company’s non-U.S. clinical diagnostic laboratory operations in Ontario. LabCorp offers services such as general and specialty laboratory testing, ambulatory monitoring services, bone marrow and human leukocyte antigen (HLA) testing, clinical trials services, drug testing services, DNA identification services, forensic identity services, health care provider services, insurance health plan services, paternity testing services, patient services, personalized medicine and hospital services. The company has a network of branches along with 44 primary laboratories and more than 1700 patient service centers. The major clients of the company are managed care organizations, physicians, hospitals, government agencies and biotechnology and pharmaceutical companies spread across all the 50 states in the US, the District of Columbia, Belgium, Puerto Rico, Japan, China, Singapore, the UK and three Canadian provinces. LabCorp is headquartered in Burlington, North Carolina, the US.



The company focuses on expanding its service portfolio through both inorganic and organic approaches. The inorganic approach includes acquisitions which can be reflected from the recent acquisition of MEDTOX Scientific, Inc. The organic approach includes in-house development of several testing technologies. These concentrated efforts will enable the company gain more market share along with better catering of clients.

Laboratory Corporation of America Holdings (LH) - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

Table Of Contents

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Laboratory Corporation of America Holdings, Medical Equipment, Deals By Year, 2008 to YTD 2014 6
Laboratory Corporation of America Holdings, Medical Equipment Deals By Type, 2008 to YTD 2014 7
Laboratory Corporation of America Holdings, Medical Equipment, Deals By Region, 2008 to YTD 2014 8
Laboratory Corporation of America Holdings, Medical Equipment, Deals By Market, 2008 to YTD 2014 9
Laboratory Corporation of America Holdings, Medical Equipment, Deals Summary, 2008 to YTD 2014 10
Laboratory Corporation of America Holdings, Medical Equipment, Deal Details 14
Venture Financing 14
Flatiron Health Raises US$8 Million In Series A Financing 14
Nodality Secures US$15.5 Million In Financing Round 16
CancerGuide Diagnostics Raises Additional US$0.7 Million In Financing Round 18
CancerGuide Secures US$10.5 Million In First Tranche Of Venture Financing 20
Partnerships 22
Ingenuity Systems Enters Into Licensing Agreement With LabCorp For Clinical Content And Applications 22
Sequella Enters Into Licensing Agreement With LabCorp For B-Smart Technology 23
LabCorp Enters Into Licensing Agreement With OPKO Health For Alzheimer's Diagnostic Technology 24
Merck Enters Into Licensing Agreement With Lab Corporation of America Holdings 25
TrovaGene Enters Into Licensing Agreement With Lab Corporation of America Holdings And InVivoScribe Technologies 26
Orchid Cellmark Enters Into Worldwide Licensing Agreement With Illumina 27
OncoMethylome Sciences Enters Into Licensing Agreement With LabCorp 28
LabCorp Enters Into Licensing Agreement With Duke University 30
Mitomics Enters Into Co-Marketing Agreement With LabCorp For Prostate Core Mitomic Test 31
XDx Enters Into Agreement With LabCorp To Develop Lupus Flare Predictor Test 32
Emdeon Enters Into Strategic Alliance With LabCorp 33
Duke University Medical Center Enters Into Joint Venture With LabCorp 34
CancerGuide Diagnostics Enters Into An Agreement With Lab Corporation of America 35
Monogram Biosciences Extends An Agreement With Pfizer 36
National Jewish Health Enters Into An Agreement With LabCorp 37
LabCorp Signs An Agreement With Vanda Pharma For Genetic Tests 38
University of Minnesota Signs Licensing Agreement With LabCorp 39
Debt Offering 40
LabCorp Completes Public Offering Of Notes Due 2018 For US$400 Million 40
LabCorp Completes Public Offering Of Notes Due 2023 For US$300 Million 42
LabCorp Completes Public Offering Of Senior Notes Due 2017 For US$500 Million 44
LabCorp Completes Public Offering Of Senior Notes Due 2022 For US$500 Million 46
LabCorp Completes An Underwritten Public Offering Of 3.125% Senior Notes Due 2016 For US$325 Million 48
LabCorp Completes An Underwritten Public Offering Of 4.625% Senior Notes Due 2020 For US$600 Million 50
Asset Transactions 52
Marken Acquires European Kit Building Operation Facility From LabCorp 52
DNA Diagnostics Center Acquires Government Paternity Business From Orchid Cellmark 53
Acquisition 54
LabCorp Acquires Minority Stake In SynapDx For US$2 Million 54
LabCorp Completes Acquisition Of Medtox Scientific For US$241 Million 55
LabCorp Completes Acquisition Of Orchid Cellmark For US$85 Million 57
Lab Corporation of America Completes Acquisition Of Genzyme Genetics From Genzyme 60
Lab Corporation Acquires DCL Medical Labs From Thompson Street Capital Partners 62
LabCorp Sells Minority Stake In Ontario, Canada Joint Venture 63
LabCorp Completes Acquisition Of Minority Stake In Ontario, Canada Joint Venture 64
Lab Corporation of America Holdings Completes Acquisition Of Monogram Biosciences 65
Laboratory Corporation of America Holdings - Key Competitors 67
Key Employees 68
Locations And Subsidiaries 69
Head Office 69
Other Locations and Subsidiaries 69
Recent Developments 73
Financial Announcements 73
Apr 28, 2014: Laboratory Corporation of America Holdings Announces 2014 First Quarter Results and Updates 2014 Guidance 73
Feb 07, 2014: Laboratory Corporation of America Announces 2013 Fourth Quarter and Full Year Results and Provides 2014 Guidance 74
Dec 10, 2013: LabCorp Updates 2013 Guidance and Provides Preliminary 2014 Guidance 75
Oct 18, 2013: Laboratory Corporation of America Announces 2013 Third Quarter Results 76
Jul 19, 2013: Laboratory Corporation of America Holdings Announces 2013 Second Quarter Results 77
Apr 19, 2013: LabCorp Reports Revenue Of $1.4 Billion In Q1 2013 78
Feb 08, 2013: LabCorp Reports Revenue Of $5.7 Billion In 2012 79
Corporate Communications 80
Mar 25, 2014: LabCorp Announces Appointment of Chief Financial Officer 80
Oct 28, 2013: Garheng Kong Named to LabCorp Board of Directors 80
Mar 11, 2013: LabCorp Announces Change to Board of Directors 81
Legal and Regulatory 81
Jan 09, 2013: LabCorp's Biorepository Receives Industry Accreditation From College Of American Pathologists 81
Government and Public Interest 81
Jan 06, 2014: LabCorp is Scheduled to Present at the 32nd Annual J.P. Morgan Healthcare Conference 81
Jan 06, 2014: LabCorp is Scheduled to Present at the 32nd Annual J.P. Morgan Healthcare Conference 82
Sep 03, 2013: LabCorp is Scheduled to Present at the Morgan Stanley Global Healthcare Conference 82
Product News 82
Dec 03, 2013: LabCorp Announces the Availability of Hepatitis C Virus Q80k Polymorphism Screening for the Newly Approved Drug OLYSIO 82
Other Significant Developments 82
Jan 29, 2014: Epic Sciences Partners with LabCorp to Accelerate European Clinical Sample Processing for Circulating Tumor Cell Technology 82
Jan 21, 2014: Illumina Signs Master Supply Agreement to Provide Next-Generation Sequencing Technologies to LabCorp 83
Apr 01, 2013: LabCorp Clinical Trials Selected As Preferred Provider For Global Central Laboratory Services By Bristol-Myers Squibb 83
Appendix 84
Methodology 84
About GlobalData 84
Contact Us 84
Disclaimer 84

List of Tables

Laboratory Corporation of America Holdings, Medical Equipment, Key Facts, 2013 1
Laboratory Corporation of America Holdings, Medical Equipment, Deals By Year, 2008 to YTD 2014 1
Laboratory Corporation of America Holdings, Medical Equipment, Deals By Region, 2008 to YTD 2014 1
Laboratory Corporation of America Holdings, Medical Equipment, Deals By Market, 2008 to YTD 2014 1
Laboratory Corporation of America Holdings, Medical Equipment, Deals Summary, 2008 to YTD 2014 1
Laboratory Corporation of America Holdings, Medical Equipment, Deals By Year, 2008 to YTD 2014 6
Laboratory Corporation of America Holdings, Medical Equipment Deals By Type, 2008 to YTD 2014 7
Laboratory Corporation of America Holdings, Medical Equipment, Deals By Region, 2008 to YTD 2014 8
Laboratory Corporation of America Holdings, Deals By Market, 2008 to YTD 2014 9
Laboratory Corporation of America Holdings, Medical Equipment, Deals Summary, 2008 to YTD 2014 10
Flatiron Health Raises US$8 Million In Series A Financing 14
Nodality Secures US$15.5 Million In Financing Round 16
CancerGuide Diagnostics Raises Additional US$0.7 Million In Financing Round 18
CancerGuide Secures US$10.5 Million In First Tranche Of Venture Financing 20
Ingenuity Systems Enters Into Licensing Agreement With LabCorp For Clinical Content And Applications 22
Sequella Enters Into Licensing Agreement With LabCorp For B-Smart Technology 23
LabCorp Enters Into Licensing Agreement With OPKO Health For Alzheimer's Diagnostic Technology 24
Merck Enters Into Licensing Agreement With Lab Corporation of America Holdings 25
TrovaGene Enters Into Licensing Agreement With Lab Corporation of America Holdings And InVivoScribe Technologies 26
Orchid Cellmark Enters Into Worldwide Licensing Agreement With Illumina 27
OncoMethylome Sciences Enters Into Licensing Agreement With LabCorp 28
LabCorp Enters Into Licensing Agreement With Duke University 30
Mitomics Enters Into Co-Marketing Agreement With LabCorp For Prostate Core Mitomic Test 31
XDx Enters Into Agreement With LabCorp To Develop Lupus Flare Predictor Test 32
Emdeon Enters Into Strategic Alliance With LabCorp 33
Duke University Medical Center Enters Into Joint Venture With LabCorp 34
CancerGuide Diagnostics Enters Into An Agreement With Lab Corporation of America 35
Monogram Biosciences Extends An Agreement With Pfizer 36
National Jewish Health Enters Into An Agreement With LabCorp 37
LabCorp Signs An Agreement With Vanda Pharma For Genetic Tests 38
University of Minnesota Signs Licensing Agreement With LabCorp 39
LabCorp Completes Public Offering Of Notes Due 2018 For US$400 Million 40
LabCorp Completes Public Offering Of Notes Due 2023 For US$300 Million 42
LabCorp Completes Public Offering Of Senior Notes Due 2017 For US$500 Million 44
LabCorp Completes Public Offering Of Senior Notes Due 2022 For US$500 Million 46
LabCorp Completes An Underwritten Public Offering Of 3.125% Senior Notes Due 2016 For US$325 Million 48
LabCorp Completes An Underwritten Public Offering Of 4.625% Senior Notes Due 2020 For US$600 Million 50
Marken Acquires European Kit Building Operation Facility From LabCorp 52
DNA Diagnostics Center Acquires Government Paternity Business From Orchid Cellmark 53
LabCorp Acquires Minority Stake In SynapDx For US$2 Million 54
LabCorp Completes Acquisition Of Medtox Scientific For US$241 Million 55
LabCorp Completes Acquisition Of Orchid Cellmark For US$85 Million 57
Lab Corporation of America Completes Acquisition Of Genzyme Genetics From Genzyme 60
Lab Corporation Acquires DCL Medical Labs From Thompson Street Capital Partners 62
LabCorp Sells Minority Stake In Ontario, Canada Joint Venture 63
LabCorp Completes Acquisition Of Minority Stake In Ontario, Canada Joint Venture 64
Lab Corporation of America Holdings Completes Acquisition Of Monogram Biosciences 65
Laboratory Corporation of America Holdings, Key Competitors 67
Laboratory Corporation of America Holdings, Key Employees 68
Laboratory Corporation of America Holdings, Other Locations 69
Laboratory Corporation of America Holdings, Subsidiaries 71

List of Figures
Laboratory Corporation of America Holdings, Medical Equipment, Deals by Type, 2008 to YTD 2014 1
Laboratory Corporation of America Holdings, Medical Equipment, Deals By Year, 2008 to YTD 2014 6
Laboratory Corporation of America Holdings, Medical Equipment, Deals by Type, 2008 to YTD 2014 7
Laboratory Corporation of America Holdings, Medical Equipment, Deals By Region, 2008 to YTD 2014 8
Laboratory Corporation of America Holdings, Medical Equipment, Deals by Market, 2008 to YTD 2014 9

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Louis

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers

Wound Management Technologies, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Wound Management Technologies, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • September 2014
  • by MarketLine

Project Synopsis: MarketLine's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

YAMASHITA MEDICAL INSTRUMENTS CO., LTD. (Symbol:3022) SWOT Analysis, Strategy, Revenues and Profits

YAMASHITA MEDICAL INSTRUMENTS CO., LTD. (Symbol:3022) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

Jiangsu Yuyue medical equipment & supply Co., Ltd. (002223) - Financial and Strategic SWOT Analysis Review

Jiangsu Yuyue medical equipment & supply Co., Ltd. (002223) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2014
  • by Global Data

Summary Jiangsu Yuwell Medical Equipment & Supply co.,Ltd (Jiangsu Yuwell) is a medical equipment company. The company manufactures and distributes medical equipment for healthcare organizations. It offers ...


1 Companies

Company Profiles


ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.